Immediate Impact

50 standout
Sub-graph 1 of 24

Citing Papers

Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Enhancement of EPR Effect for Passive Tumor Targeting: Current Status and Future Perspectives
2025 Standout
2 intermediate papers

Works of Bing Jia being referenced

Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects
2019

Author Peers

Author Last Decade Papers Cites
Bing Jia 216 317 146 36 483
André Rüffer 173 220 276 53 573
James C. Fudge 107 215 236 25 481
Grażyna Brzezińska‐Rajszys 391 407 135 35 573
David Mishaly 183 210 263 38 510
Robert K. Darragh 226 343 253 33 562
Bertrand Stos 176 327 165 43 500
Jesse J. Esch 206 289 178 27 541
Andrew L. Rivard 64 92 234 34 479
Timothy B. Cartmill 266 283 291 22 556
Camilla Nyboe 336 389 131 36 561

All Works

Loading papers...

Rankless by CCL
2026